Ligand Pharmaceuticals Incorporated (LGND) Directors and Executive Officers - CSIMarket
CSIMarket
 
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)

Ligand Pharmaceuticals Incorporated

Officers & Directors


JOHN W. KOZARICH
Director and Chairman of the Board -

JOHN L. LAMATTINA
Director -

STEPHEN L. SABBA
Director -

NANCY R. GRAY
Director -

MARTINE ZIMMERMANN
Director -

TODD C. DAVIS
Chief Executive Officer and Director (Principal Executive Officer) -

JASON HAAS
Director -

JASON M. ARYEH
Director -

OCTAVIO ESPINOZA
Chief Financial Officer (Principal Financial and Accounting Officer) - ,

Ligand Pharmaceuticals Incorporated currently has 47 employees.






LGND Management Effectiveness LGND Revenue per Employee LGND Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.